Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: Involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems

International Journal of Neuropsychopharmacology

Volumn 13, Issue 10, 2010, Pages 1343-1354

  Noda, Yukihiro ^a   Mouri, Akihiro ^a   Ando, Yu ^a   Waki, Yukari ^a   Yamada, Shin Nosuke ^a   Yoshimi, Akira ^a,b   Yamada, Kiyofumi ^b   Ozaki, Norio ^b   Wang, Dayong ^a   Nabeshima, Toshitaka ^a,c  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NONE   (Japan)

Author keywords

Allosteric potentiation of nicotinic acetylcholine receptors; cognitive impairment; dopamine; extracellular signal regulated kinase 1 2; galantamine; methamphetamine

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DONEPEZIL; DOPAMINE; GALANTAMINE; MECAMYLAMINE; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINIC RECEPTOR; SCOPOLAMINE; ACETYLCHOLINE; ADRENERGIC RECEPTOR AFFECTING AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; INDAN DERIVATIVE; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC RECEPTOR; PIPERIDINE DERIVATIVE;

ALLOSTERISM; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; MALE; MEMORY DISORDER; MOUSE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RECOGNITION; ANIMAL; COGNITION; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; MEMORY; METABOLISM;

ACETYLCHOLINE; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CHOLINESTERASE INHIBITORS; COGNITION; DOPAMINE; DOPAMINE AGONISTS; GALANTAMINE; INDANS; MALE; MEMORY; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PIPERIDINES; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; RECOGNITION (PSYCHOLOGY);

EID: 79952668364     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000222     Document Type: Article

References (29)

1. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, et al. (2003). Treatment of methamphetamine abuse: research findings and clinical directions. Journal of Substance Abuse Treatment 24, 267-277. (Pubitemid 37297344)
2. Dias R, Robbins TW, Roberts AC (1996a). Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380, 69-72. (Pubitemid 26076238)
3. Dias R, Robbins TW, Roberts AC (1996b). Primate analogue of the Wisconsin card sorting test : effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behavioral Neuroscience 110, 872-886. (Pubitemid 26365787)
4. Eisele JL, Bertrand S, Galzi JL, Devillers-Thiery A, et al. (1993). Chimaeric nicotinic-serotoninergic receptor combines distinct ligand binding and channel specificities. Nature 366, 479-483. (Pubitemid 24013884)
5. Franklin KBJ, Paxinos G (1996). The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press.
6. Friedman JI (2004). Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology (Berlin) 174, 45-53. (Pubitemid 38925090)
7. Geerts H, Guillaumat PO, Grantham C, Bode W, et al. (2005). Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice and rabbits. Brain Research 1033, 186-193. (Pubitemid 40193413)
8. Ito Y, Takuma K, Mizoguchi H, Nagai T, et al. (2007). A novel azaindolizinone derivative ZSET1446 [spiro[imidazo[1,2-a]pyridine-3,2-indan]- 2(3H)-one] improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. Journal of Pharmacology and Experimental Therapeutics 320, 819-827. (Pubitemid 46147964)
9. Kalechstein AD, Newton TF, Green M (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neurosciences 15, 215-220. (Pubitemid 36520342)
10. Kamei H, Nagai T, Nakano H, Togan Y, et al. (2006). Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biological Psychiatry 59, 75-84. (Pubitemid 43005238)
11. Mizoguchi H, Yamada K, Mizuno M, Mizuno T, et al. (2004). Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Molecular Pharmacology 65, 1293-1301. (Pubitemid 38543500)
12. Mouri A, Noda Y, Noda A, Nakamura T, et al. (2007). Involvement of a dysfunctional dopamine-D1/N-methyld- aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Molecular Pharmacology 71, 1598-1609. (Pubitemid 47010913)
13. Mouri A, Zou LB, Iwata N, Saido TC, et al. (2006). Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory. Behavioral Brain Research 168, 83-91. (Pubitemid 43152056)
14. Nordahl TE, Salo R, Leamon M (2003). Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. Journal of Neuropsychiatry and Clinical Neurosciences 15, 317-325. (Pubitemid 36999374)
15. Paulus MP, Hozack NE, Zauscher BE, Frank L, et al. (2002). Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26, 53-63. (Pubitemid 34075276)
16. Rawson RA, Gonzales R, Brethen P (2002). Treatment of methamphetamine use disorders : an update. Journal of Substance Abuse Treatment 23, 145-150. (Pubitemid 36151695)
17. Santos MD, Alkondon M, Aracava Y, Eisenberg HM, et al. (2002). The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Molecular Pharmacology 61, 1222-1234. (Pubitemid 34441788)
18. Sato M, Chen CC, Akiyama K, Otsuki S (1983). Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry 18, 429-440. (Pubitemid 13121482)
19. Sawaguchi T, Goldman-Rakic PS (1991). D1 dopamine receptors in prefrontal cortex : involvement in working memory. Science 251, 947-950. (Pubitemid 21926192)
20. Schilström B, Ivanov VB, Wiker C, Svensson TH (2007). Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. Neuropsychopharmacology 32, 43-53. (Pubitemid 44967783)
21. Shintani F, Kanba S, Nakaki T, Nibuya M, et al. (1993). Interleukin-1b augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. Journal of Neuroscience 13, 3574-3581. (Pubitemid 23241191)
22. Simon SL, Domier C, Carnell J, Brethen P, et al. (2000). Cognitive impairment in individuals currently using methamphetamine. American Journal on Addictions 9, 222-231.
23. Srisurapanont M, Ali R, Marsden J, Sunga A, et al. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology 6, 347-352. (Pubitemid 38146252)
24. Valjent E, Corvol JC, Pages C, Besson MJ, et al. (2000). Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. Journal of Neuroscience 20, 8701-8709.
25. Wang D, Noda Y, Zhou Y, Mouri A, et al. (2007a). The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems. Neuropsychopharmacology 32, 1261-1271. (Pubitemid 46788859)
26. Wang D, Noda Y, Zhou Y, Nitta A, et al. (2007b). Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission. Neuropharmacology 53, 379-389. (Pubitemid 47212249)
27. Winters BD, Saksida LM, Bussey TJ (2008). Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval. Neuroscience and Biobehavioral Reviews 32, 1055-1070.
28. Yui K, Ikemoto S, Goto K, Nishijima K, et al. (2002). Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects : susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry 35, 62-71. (Pubitemid 34293235)
29. Zanassi P, Paolillo M, Feliciello A, Avvedimento EV, et al. (2001). cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. Journal of Biological Chemistry 276, 11487-11495.